Skip to main content
  • STEROHCA: Methylprednisolone Reduces Inflammation, but Not Cardiac or Neurological Injury, vs. Placebo in Resuscitated OHCA Patients

    PHILADELPHIA – Methylprednisolone significantly reduced interleukin (IL)-6 levels in patients resuscitated after out-of-hospital cardiac arrest (OHCA) compared to placebo, new trial results show.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details